---
title: "Artisan Partners Reports $186 Billion in AUM for May"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288904273.md"
description: "Artisan Partners Asset Management reported preliminary assets under management of $186 billion as of May 31, 2026. The firm also announced that a US sub-advisory mandate of approximately $5.7 billion in its Value Equity strategy is expected to terminate in early June, though the company stated the impact on revenues would be muted."
datetime: "2026-06-05T20:27:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288904273.md)
  - [en](https://longbridge.com/en/news/288904273.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288904273.md)
generator: "portal-rs"
---

# Artisan Partners Reports $186 Billion in AUM for May

04:27 PM EDT, 06/05/2026 (MT Newswires) -- Artisan Partners Asset Management ( APAM ) reported preliminary assets under management of $186 billion as of May 31, 2026, with Artisan Funds and Artisan Global Funds accounting for $92.3 billion and separate accounts making up the remaining $93.7 billion.

The company said Friday it was notified that a US sub-advisory mandate of about $5.7 billion in its Value Equity strategy is expected to terminate in early June, though it added the impact on revenues would be muted given the nature of the mandate and its associated fees.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [APAM.US](https://longbridge.com/en/quote/APAM.US.md)

## Related News & Research

- [BREAKINGVIEWS-For Novartis, M&A is both a disease and cure](https://longbridge.com/en/news/298726698.md)
- [Artisan Partners cuts Sodexo stake below 10% threshold, AMF filing shows](https://longbridge.com/en/news/298054911.md)
- [Top Investor Urges Novartis for Stronger Acquisition Oversight After M&A and Trial Setbacks](https://longbridge.com/en/news/298740495.md)
- [Snap Could Be 23% Undervalued As New Ad Tools And Leadership Lift Optimism](https://longbridge.com/en/news/298812469.md)
- [EXCLUSIVE-Major Novartis shareholder calls for board shake-up after drug trial setbacks](https://longbridge.com/en/news/298577211.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**